(220) found that inhibition of ALDH2 resulted in decreased PD-L1 protein levels in colorectal cancer (CRC) cells, thereby promoting the infiltration of tumor-infiltrating lymphocytes (TILs) and facilitating the escape of colorectal tumors from immune surveillance. The gene discussed is ALDH2; the disease is colorectal carcinoma.